Technical Scrutiny: Isis Pharma, Community Health Systems, ZIOPHARM Oncology, and Alere

Technical Scrutiny: Isis Pharma, Community Health Systems, ZIOPHARM Oncology,
                                  and Alere

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

LONDON, July 2, 2013

LONDON, July 2, 2013 /PRNewswire/ --

The U.S. equity market kicked off the third quarter of 2013 on a positive note
as all three benchmark indexes edged higher on Monday, July 1, 2013. Stocks
gained as better-than-expected ISM manufacturing and construction spending
data lifted market sentiment. However, all three benchmark indexes finished
well off their session highs. The healthcare sector was among the major
gainers in the S&P 500 on Monday, and the major movers in this sector included
ISIS Pharmaceuticals Inc. (NASDAQ: ISIS), Community Health Systems (NYSE:
CYH), ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), and Alere Inc. (NYSE: ALR).
AAAResearchReports.com tracked ISIS, CYH, ZIOP, and ALR. These reports can be
seen for free at:

http://www.aaaresearchreports.com/register/ 

Shares in ISIS Pharmaceuticals Inc. surged on Monday, hitting a 52-week high
of $29.08. The stock finished 5.95% higher at $28.47. A total of 1.69 million
shares were traded which is slightly above the daily average volume of 1.65
million. ISIS Pharma's shares are currently trading above their 50-day and
200-day moving averages. In the last three months, the company's shares have
gained 67.27%, thus outperforming the S&P 500. Download free research on ISIS
by signing up now at:

http://www.AAAResearchReports.com/ISIS070213.pdf

Community Health Systems' stock edged higher on Monday, extending its gains
from previous trading sessions. The company's shares closed the day 0.32%
higher at $47.03 after oscillating between $46.84 and $47.56. A total of
664,938 shares were traded which is below the daily average volume of 1.19
million. The company's shares have gained 1.49% in the last three trading
sessions, but have declined 2.08% in the last three months. Moreover, the
stock is currently trading near its 52-week high of $51.29. Register for
today's free analysis on CYH at:

http://www.AAAResearchReports.com/CYH070213.pdf

Shares in ZIOPHARM Oncology Inc. fluctuated between $2.07 and $2.23 before
closing the day flat at $2.11. A total of 615,496 shares were traded which is
below the daily average volume of 1.86 million. ZIOPHARM's shares have gained
6.57% in the last three trading sessions and 19.89% in the last three months.
A free report on ZIOP can be accessed by registering at:

http://www.AAAResearchReports.com/ZIOP070213.pdf

Alere Inc.'s stock rose sharply on Monday, tracking gains in the broader
market. The company's shares ended the day 2.24% higher at $25.05 after
oscillating between $24.53 and $25.22. A total of 526,399 shares were traded
which is above the daily average volume of 473,067. Alere's shares have fallen
2.19% in the last three months. The stock is still trading above its 200-day
moving average. Register with AAA Research Reports and download research on
ALR for free at:

http://www.AAAResearchReports.com/ALR070213.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

SOURCE AAA Research Reports

Contact: AAAresearchreports.com Phone #: + 1 (646) 396-9126
 
Press spacebar to pause and continue. Press esc to stop.